Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2006 1
2009 1
2010 2
2011 3
2015 1
2018 1
2020 3
2021 3
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer.
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA Jr, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Smith KL, Ferreiro T, Ribi K, Ruddy K, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Pagani O; International Breast Cancer Study Group; POSITIVE Trial Collaborators. Partridge AH, et al. Among authors: borstnar s. N Engl J Med. 2023 May 4;388(18):1645-1656. doi: 10.1056/NEJMoa2212856. N Engl J Med. 2023. PMID: 37133584 Free PMC article. Clinical Trial.
Full population results from the core phase of CompLEEment-1, a phase 3b study of ribociclib plus letrozole as first-line therapy for advanced breast cancer in an expanded population.
De Laurentiis M, Borstnar S, Campone M, Warner E, Bofill JS, Jacot W, Dent S, Martin M, Ring A, Cottu P, Lu J, Ciruelos E, Azim HA, Chatterjee S, Zhou K, Wu J, Menon-Singh L, Zamagni C. De Laurentiis M, et al. Among authors: borstnar s. Breast Cancer Res Treat. 2021 Oct;189(3):689-699. doi: 10.1007/s10549-021-06334-0. Epub 2021 Aug 19. Breast Cancer Res Treat. 2021. PMID: 34414532 Free PMC article. Clinical Trial.
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment.
Dobovišek L, Krstanović F, Borštnar S, Debeljak N. Dobovišek L, et al. Among authors: borstnar s. Cancers (Basel). 2020 Feb 25;12(3):525. doi: 10.3390/cancers12030525. Cancers (Basel). 2020. PMID: 32106399 Free PMC article. Review.
Management Strategies for Hyperglycemia Associated with the α-Selective PI3K Inhibitor Alpelisib for the Treatment of Breast Cancer.
Tankova T, Senkus E, Beloyartseva M, Borštnar S, Catrinoiu D, Frolova M, Hegmane A, Janež A, Krnić M, Lengyel Z, Marcou Y, Mazilu L, Mrinakova B, Percik R, Petrakova K, Rubovszky G, Tokar M, Vrdoljak E. Tankova T, et al. Among authors: borstnar s. Cancers (Basel). 2022 Mar 22;14(7):1598. doi: 10.3390/cancers14071598. Cancers (Basel). 2022. PMID: 35406370 Free PMC article. Review.
Ribociclib plus letrozole in patients with hormone receptor-positive, HER2-negative advanced breast cancer with no prior endocrine therapy: subgroup safety analysis from the phase 3b CompLEEment-1 trial.
Borstnar S, Palacova M, Łacko A, Timcheva C, Gal-Yam EN, Papazisis K, Beniak J, Kudela P, Rubovszky G. Borstnar S, et al. Radiol Oncol. 2022 May 17;56(2):238-247. doi: 10.2478/raon-2022-0020. Radiol Oncol. 2022. PMID: 35575587 Free PMC article. Clinical Trial.
Factors associated with a high level of unmet needs and their prevalence in the breast cancer survivors 1-5 years after post local treatment and (neo)adjuvant chemotherapy during the COVID-19: A cross-sectional study.
Miroševič Š, Prins J, Borštnar S, Besić N, Homar V, Selič-Zupančič P, Smrdel ACŠ, Klemenc-Ketiš Z. Miroševič Š, et al. Among authors: borstnar s. Front Psychol. 2022 Oct 3;13:969918. doi: 10.3389/fpsyg.2022.969918. eCollection 2022. Front Psychol. 2022. PMID: 36262447 Free PMC article.
Evaluation of an Early Individualized Integrated Rehabilitation Program versus Standard Rehabilitation Program for Smoking Cessation in 115 Smokers Among 467 Female Breast Cancer Patients 2019-2021 in Slovenia.
Cencelj Arnez R, Besic N, Mavric Z, Mozetic A, Zagar T, Homar V, Kopcavar Gucek N, Skufca Smrdel AC, Knific J, Borstnar S, Zadravec Zaletel L, Kos N, Strazisar B, Mastnak Mlakar D, Kovacevic N, Hadzic V, Pelhan B, Sremec M, Rozman T, Pribakovic Brinovec R, Kurir Borovcic M. Cencelj Arnez R, et al. Among authors: borstnar s. Med Sci Monit. 2023 Dec 2;29:e942272. doi: 10.12659/MSM.942272. Med Sci Monit. 2023. PMID: 38041401 Free PMC article.
25 results